Yusuke Suzuki

1978–2026 年に発表

342
論文数
21,092
被引用数
76
h 指数
218
i10 指数

被引用数

Yusuke Suzuki の年別被引用数1979 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 3 件1996 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 1 件2000 年: 被引用 4 件2001 年: 被引用 12 件2002 年: 被引用 41 件2003 年: 被引用 50 件2004 年: 被引用 64 件2005 年: 被引用 83 件2006 年: 被引用 76 件2007 年: 被引用 82 件2008 年: 被引用 87 件2009 年: 被引用 96 件2010 年: 被引用 90 件2011 年: 被引用 104 件2012 年: 被引用 105 件2013 年: 被引用 95 件2014 年: 被引用 152 件2015 年: 被引用 143 件2016 年: 被引用 120 件2017 年: 被引用 162 件2018 年: 被引用 189 件2019 年: 被引用 490 件2020 年: 被引用 594 件2021 年: 被引用 685 件2022 年: 被引用 650 件2023 年: 被引用 700 件2024 年: 被引用 1,260 件2025 年: 被引用 573 件2026 年: 被引用 27 件1980〜1990 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,573 件、この内訳の 17.8%中国: 引用元論文 1,200 件、この内訳の 13.6%日本: 引用元論文 868 件、この内訳の 9.8%イギリス: 引用元論文 545 件、この内訳の 6.2%ドイツ: 引用元論文 426 件、この内訳の 4.8%イタリア: 引用元論文 364 件、この内訳の 4.1%カナダ: 引用元論文 314 件、この内訳の 3.6%オーストラリア: 引用元論文 297 件、この内訳の 3.4%フランス: 引用元論文 265 件、この内訳の 3%スペイン: 引用元論文 249 件、この内訳の 2.8%オランダ: 引用元論文 199 件、この内訳の 2.3%韓国: 引用元論文 154 件、この内訳の 1.7%
0%17.8%その他 26.9%

分野

  • Medicine57.7%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Computer Science9.6%
  • Immunology and Microbiology7.4%
  • Neuroscience4.5%
  • Engineering1.7%
  • その他6%

トピック

  • Renal Diseases and Glomerulopathies6.9%
  • Chronic Kidney Disease and Diabetes4.5%
  • Asthma and respiratory diseases2.1%
  • Vasculitis and related conditions2%
  • Dialysis and Renal Disease Management1.7%
  • IL-33, ST2, and ILC Pathways1.6%
  • その他81.2%

共著者

全論文

検索で開く
  1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2021 被引用: 2,416

  2. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege - Kidney International 2021 被引用: 791

  3. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Fernanda Soares, Yusuke Suzuki, Katsuo Takahashi, Stéphan Troyanov, Jacobien C. Verhave, Suxia Wang, Jan J. Weening, Robert Wyatt, Nori Yoshikawa, Caihong Zeng - Kidney International 2017 被引用: 1,171

  4. An update on the global disparities in kidney disease burden and care across world countries and regions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Smita Divyaveer, Udeme E. Ekrikpo, Isabelle Ethier, Winston Wing-Shing Fung, Abduzhappar Gaipov, Anukul Ghimire, Ghenette Houston, Kwaifa Salihu Ibrahim, Georgina Irish, Kailash Jindal, Dearbhla M. Kelly, Liz Lightstone, Magdalena Madero, Aisha M. Nalado, Brendon L. Neuen, Timothy O. Olanrewaju, Mohamed A. Osman, Rulan S. Parekh, Anna Petrova, Narayan Prasad, Larisa Prikhodina, Sanjin Racki, Parnian Riaz, Syed Saad, Aminu Muhammad Sakajiki, Shokoufeh Savaj, Dibya Singh Shah, Yusuke Suzuki, Vladimir Tesar, Sophanny Tiv, Somkanya Tungsanga, Carmen Tzanno-Martins, Andrea Viecelli, Angela Yee-Moon Wang, Muh Geot Wong, Deenaz Zaidi - The Lancet Global Health 2024 被引用: 449

  5. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gloria Ashuntantang, Shakti Basnet, Aminu K. Bello, Worawon Chailimpamontree, Ricardo Correa‐Rotter, Jonathan C. Craig, Walter Douthat, Harold I. Feldman, Mohammad Reza Ganji, Guillermo García-García, Mohammed Benghanem Gharbi, David C.H. Harris, Vivekanand Jha, David W. Johnson, Rümeyza Kazancıoğlu, Robyn G. Langham, Zhi-Hong Liu, Ziad A. Massy, Masaomi Nangaku, Robert G. Nelson, Dónal O’Donoghue, Ikechi G. Okpechi, Roberto Pecoits‐Filho, Neil R. Powe, Giuseppe Remuzzi, Charlotte Roberts, Jérôme Rossert, Laura Solá, Bénédicte Stengel, Ernest K. Sumaili M, Yusuke Suzuki, Tetsuhiro Tanaka, Sajja Tatiyanupanwong, Bernadette Thomas, Katrin Uhlig, Robert G. Walker, S. L. White, Andrzej Więcek, Chih-Wei Yang - The Lancet 2017 被引用: 923

  6. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

    著者: , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 196

  7. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

    著者: , , , , , , , , , , , , , - JAMA Internal Medicine 2019 被引用: 475

  8. Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 113

  9. Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria

    著者: , , , , , , , , - Kidney International Reports 2022 被引用: 92

  10. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation

    著者: , , , , , , , , - Nature Communications 2013 被引用: 339

  11. Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rana S. Hinman, M. Hopman-Rock, Michael Hurley, Justin Keogh, Cindy Veenhof, J. Knoop, Inga Krauß, Pazit Levinger, Christopher J. McCarthy, Stephen P. Messier, Ari Heinonen, Håvard Østerås, Shahnawaz Anwer, Ana Cristina Rodrigues Lacerda, G. Shankar Ganesh, Benjamin Steinhilber, Yusuke Suzuki, Michael A. Hunt, Laura A. Talbot, C.H. Teirlinck, Michael Doherty, Pao‐Feng Tsai, Jason A. Wallis, Merve Yılmaz Menek - The Lancet Rheumatology 2023 被引用: 123

  12. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy

    著者: , , , , , , - Kidney International 2019 被引用: 161

  13. Inflammation and angiotensin II

    著者: , , , , , - The International Journal of Biochemistry & Cell Biology 2003 被引用: 692

  14. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2009 被引用: 453

  15. Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy

    著者: , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 被引用: 143

  16. Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy

    著者: , , , , , , , , , , , , - Science Advances 2023 被引用: 64

  17. Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme

    著者: , , , , , , , , , , , , , , , - Frontiers in Microbiology 2020 被引用: 53

  18. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 225

  19. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

    著者: , , , , , , , , , , , , - Kidney International 2019 被引用: 90

  20. Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study

    著者: , , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2022 被引用: 44

  21. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonello Pani, Doloretta Piras, Andrea Angioi, Giovanni Cancarini, S. Ravera, Magdalena Durlik, Elisabetta Moggia, José Ballarín, S. Di Giulio, Francesco Pugliese, I. Serriello, Y. Caliskan, Mehmet Şükrü Sever, İşın Kiliçaslan, Francesco Locatelli, Lucia Del Vecchio, Jack F.M. Wetzels, Harm Peters, U. Berg, Fernanda Carvalho, A.C. da Costa Ferreira, M. Maggio, Andrzej Więcek, Mai Ots-Rosenberg, Riccardo Magistroni, Rezan Topaloğlu, Yelda Bilginer, Marco DʼAmico, Μaria Stangou, F Giacchino, Dimitrios Goumenos, Evangelos Papachristou, Kres̆imir Gales̃ić, Colin Geddes, Kostas C. Siamopoulos, Olga Balafa, Marco Galliani, Piero Stratta, Marco Quaglia, R Bergia, Raffaella Cravero, Maurizio Salvadori, Lino Cirami, Bengt Fellström, Hilde Kloster Smerud, Franco Ferrario, T. Stellato, Jesús Egido, Carina Aguilar Martín, Jürgen Floege, Frank Eitner, Antonio Lupo, Patrizia Bernich, Paolo Mené, Massimo Morosetti, Cees van Kooten, Ton J. Rabelink, Marlies E. J. Reinders, J.M. Boria Grinyo, Stefano Cusinato, Luisa Benozzi, Silvana Savoldi, C. Licata, Małgorzata Mizerska-Wasiak, G Martina, A Messuerotti, Antonio Dal Canton, Ciro Esposito, C. Migotto, G Triolo ほか 102 名 - Kidney International 2022 被引用: 76

  22. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis

    著者: , , , , , , , - Kidney International 2018 被引用: 227

  23. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers

    著者: , , , , , , , - Kidney International Reports 2022 被引用: 44

  24. Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy

    著者: , , , , , , , , , , , , - Nephrology Dialysis Transplantation 2024 被引用: 33